Lart Bio Overview
- Founded
- 2016
- Status
- Out of Business
- Latest Deal Type
- Out of Business
Lart Bio General Information
Description
Developer of a genetic scissors (calibration) technology intended for application to industrial bio-models. The company's technology has applications in bovine fertilized egg transplantation, development and supply of non-viral cell lines, development and production of genetically displaced rats, production of functional milk and albumin through genetically modified cows, development and production of animal pharmaceuticals and cosmetic materials, enabling clients to do commercialization in functional milk, animals or human markets.
Contact Information
Primary Industry
Biotechnology
Primary Office
- 1, 38, Nakseongdae-ro Gwanak-gu
- Seoul, 08790
- South Korea
Lart Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Apr-2020 | Completed | Out of Business | |||
| 3. Early Stage VC | Completed | Startup | ||||
| 2. Accelerator/Incubator | 01-Nov-2017 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2017 | Completed | Startup |
Lart Bio Patents
Lart Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2020534789-A | Transgenic animals and transgenic embryos that produce modified nucleases | Pending | 16-Aug-2018 | 00000000 | 0 |
| AU-2021232801-A1 | Transgenic animals and transgenic embryos producing an engineered nuclease | Pending | 16-Aug-2018 | 00000000 | |
| AU-2019275586-B2 | Transgenic animals and transgenic embryos producing an engineered nuclease | Active | 16-Aug-2018 | 00000000 | 0 |
| US-20210337776-A1 | Transgenic animals and transgenic embryos producing an engineered nuclease | Pending | 16-Aug-2018 | 00000000 | |
| AU-2021232802-A1 | Transgenic animals and transgenic embryos producing an engineered nuclease | Pending | 16-Aug-2018 | C12N9/22 |